BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 23466435)

  • 1. Vital signs: carbapenem-resistant Enterobacteriaceae.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(9):165-70. PubMed ID: 23466435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.
    Kotb S; Lyman M; Ismail G; Abd El Fattah M; Girgis SA; Etman A; Hafez S; El-Kholy J; Zaki MES; Rashed HG; Khalil GM; Sayyouh O; Talaat M
    Antimicrob Resist Infect Control; 2020; 9(1):2. PubMed ID: 31911830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
    Netikul T; Kiratisin P
    PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.
    Brennan BM; Coyle JR; Marchaim D; Pogue JM; Boehme M; Finks J; Malani AN; VerLee KE; Buckley BO; Mollon N; Sundin DR; Washer LL; Kaye KS
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):342-9. PubMed ID: 24602937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from initial reporting of carbapenem-resistant Enterobacteriaceae in New York State hospitals, 2013-2014.
    Mayer CL; Haley VB; Giardina R; Hazamy PA; Tsivitis M; Knab R; Lutterloh E
    Am J Infect Control; 2016 Feb; 44(2):131-3. PubMed ID: 26601706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD; Shorr AF
    J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.
    Guh AY; Bulens SN; Mu Y; Jacob JT; Reno J; Scott J; Wilson LE; Vaeth E; Lynfield R; Shaw KM; Vagnone PM; Bamberg WM; Janelle SJ; Dumyati G; Concannon C; Beldavs Z; Cunningham M; Cassidy PM; Phipps EC; Kenslow N; Travis T; Lonsway D; Rasheed JK; Limbago BM; Kallen AJ
    JAMA; 2015 Oct; 314(14):1479-87. PubMed ID: 26436831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.
    Chea N; Bulens SN; Kongphet-Tran T; Lynfield R; Shaw KM; Vagnone PS; Kainer MA; Muleta DB; Wilson L; Vaeth E; Dumyati G; Concannon C; Phipps EC; Culbreath K; Janelle SJ; Bamberg WM; Guh AY; Limbago B; Kallen AJ
    Emerg Infect Dis; 2015 Sep; 21(9):1611-6. PubMed ID: 26290955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States.
    Thaden JT; Lewis SS; Hazen KC; Huslage K; Fowler VG; Moehring RW; Chen LF; Jones CD; Moore ZS; Sexton DJ; Anderson DJ
    Infect Control Hosp Epidemiol; 2014 Aug; 35(8):978-83. PubMed ID: 25026612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):256-60. PubMed ID: 19300408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017.
    Woodworth KR; Walters MS; Weiner LM; Edwards J; Brown AC; Huang JY; Malik S; Slayton RB; Paul P; Capers C; Kainer MA; Wilde N; Shugart A; Mahon G; Kallen AJ; Patel J; McDonald LC; Srinivasan A; Craig M; Cardo DM
    MMWR Morb Mortal Wkly Rep; 2018 Apr; 67(13):396-401. PubMed ID: 29621209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty-day laboratory-based surveillance for carbapenem-resistant Enterobacteriaceae in the Minneapolis-St. Paul metropolitan area.
    Pereira EC; Shaw KM; Vagnone PM; Harper JE; Kallen AJ; Limbago BM; Lynfield R
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):423-5. PubMed ID: 24602949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.
    Lee BY; Bartsch SM; Wong KF; McKinnell JA; Slayton RB; Miller LG; Cao C; Kim DS; Kallen AJ; Jernigan JA; Huang SS
    Am J Epidemiol; 2016 Mar; 183(5):471-9. PubMed ID: 26861238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of an enhanced surveillance program for carbapenem-resistant Enterobacteriaceae.
    Fitzpatrick M; Zembower T; Malczynski M; Qi C; Bolon MK
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):419-22. PubMed ID: 24602948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Distribution of Educational Materials for Carbapenem-Resistant Enterobacteriaceae Among Acute and Long-term Care Facilities.
    Kram JJ; Borlaug G; Safdar N; Sethi A
    WMJ; 2015 Apr; 114(2):48-51. PubMed ID: 26756056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
    Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.